Exploring Neurotechnology with Ana Maiques: A Conversation on Innovation and Impact
This week on the EU-Startups Podcast, we had the pleasure of speaking with Ana Maiques, the CEO and co-founder of Neuroelectrics, a pioneering neurotechnology company based in Barcelona. Founded in 2011 as a spin-off from Starlab, Neuroelectrics is at the forefront of non-invasive brain stimulation, aiming to transform the treatment landscape for neurological and psychiatric conditions.
The Journey of Neuroelectrics
Neuroelectrics has made significant strides since its inception, evolving into a global digital brain health company that operates in over 74 countries. With a dual presence in Barcelona and Boston since 2014, the company has developed technology that allows clinicians to both read and influence brain activity in real-time. This innovation holds promise for treating conditions such as epilepsy, depression, Alzheimer’s disease, Parkinson’s disease, and anxiety disorders.
The Evolution of Neurotechnology
During our conversation, Maiques highlighted how the neurotechnology landscape has transformed over the past decade. Once a niche research field, it has rapidly grown into a sector that attracts substantial investment and interest. The advancements in technology have not only opened new avenues for treatment but have also sparked discussions about the ethical implications and the future of brain health.
Collaboration with NASA
One of the most fascinating aspects of Neuroelectrics’ journey is its collaboration with NASA. The company’s technology has been utilized to measure cognitive fatigue in pilots, showcasing the versatility and applicability of their innovations beyond traditional healthcare settings. This partnership underscores the potential of neurotechnology to enhance performance in high-stakes environments, further validating its importance in various fields.
Challenges in Scaling DeepTech Companies
Maiques also delved into the structural challenges that DeepTech companies face, particularly in Europe compared to the United States. Access to capital, talent, and regulatory pathways can be significant hurdles for scaling operations. The funding gap between Europe and the US remains a pressing issue, and Maiques emphasized the need for a more supportive ecosystem to foster innovation in the region.
The Impact of COVID-19 on Telemedicine
The COVID-19 pandemic has accelerated the adoption of remote brain treatment and telemedicine solutions. Maiques discussed how the crisis prompted a shift in the way healthcare is delivered, making it more accessible for patients who may have previously faced barriers to receiving care. This evolution has opened up new possibilities for Neuroelectrics and similar companies to reach a broader audience.
Gender Diversity in STEM
Another important topic that emerged during our discussion was the current state of gender diversity in STEM fields. Maiques shared her insights on the progress made and the areas where further efforts are needed. As a leader in a tech-driven industry, she advocates for increased representation and support for women in science and technology, recognizing the value of diverse perspectives in driving innovation.
Key Takeaways
Throughout the podcast episode, several key points emerged:
-
Personalized Treatments: Neuroelectrics was founded to address the lack of personalized and effective treatments for brain disorders, emphasizing the need for tailored approaches in healthcare.
-
Advantages of Non-Invasive Techniques: Non-invasive brain stimulation offers significant advantages over surgical approaches, making it a safer and more accessible option for patients.
-
Telemedicine’s Rise: The pandemic has accelerated the shift towards remote treatment options, highlighting the importance of adaptability in healthcare delivery.
-
Funding and Support: The challenges of scaling DeepTech companies in Europe underscore the need for improved access to funding and resources.
-
Advocacy for Diversity: The conversation around gender diversity in STEM is crucial for fostering a more inclusive and innovative environment.
This engaging discussion with Ana Maiques not only sheds light on the advancements in neurotechnology but also highlights the broader implications for healthcare, innovation, and diversity in the tech industry.
For those interested in diving deeper into this fascinating topic, you can listen to the full episode here.
